Universe Pharmaceuticals stock hits 52-week low at 1.78 By Investing.com - Investing.com Australia
| UPC Stock | USD 1.86 0.07 3.63% |
About 60% of Universe Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Universe Pharmaceuticals suggests that many traders are alarmed. The current market sentiment, together with Universe Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Universe Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Universe |
Universe Pharmaceuticals stock hits 52-week low at 1.78 By Investing.com Investing.com Australia
Read at news.google.com
 |
Universe Pharmaceuticals Fundamental Analysis
We analyze Universe Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Universe Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Universe Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Institutions
Shares Owned By Institutions Comparative Analysis
Universe Pharmaceuticals is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Universe Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Universe Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Universe Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Universe Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Universe Pharmaceuticals Related Equities
| PROC | Procaps Group | 38.04 | ||||
| PAHC | Phibro Animal | 1.68 | ||||
| RGC | Regencell Bioscience | 0.68 | ||||
| RAPH | Raphael Pharmaceutical | 0.00 | ||||
| IMCC | Im Cannabis | 0.77 | ||||
| TKNO | Alpha Teknova | 1.91 |
Complementary Tools for Universe Stock analysis
When running Universe Pharmaceuticals' price analysis, check to measure Universe Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universe Pharmaceuticals is operating at the current time. Most of Universe Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Universe Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universe Pharmaceuticals' price. Additionally, you may evaluate how the addition of Universe Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |